XenoGesis has invested in GastroPlus™, a software package that simulates absorption, distribution, metabolism and elimination in humans and animals from a range of dose routes including oral, intravenous, inhaled, ocular and dermal. This enables data to be integrated within the context of a virtual animal or a human model. Having this in silico understanding can help us make faster and more informed development decisions. It has been identified as the number one commercially ranked program for in vitro-in vivo extrapolation and has been the focus of several publications from the FDA.
© 2019 XenoGesis | BioCity Nottingham | Pennyfoot Street | Nottingham | NG1 1GF | UK
If you’d like to get in touch with one of our scientists, please click here!